Syndax Pharmaceuticals
Latest round
- Series C
Last raised
- Aug 2015
Total raised
- $142M
Investors
- 17
About Syndax Pharmaceuticals
Syndax Pharmaceuticals, Inc.Founded in 2005 and headquartered in New York, US, Syndax Pharmaceuticals specializes in oncology drug development.Syndax Pharmaceuticals specializes in developing innovative oncology therapies aimed at treating significant unmet medical needs, particularly in acute leukemia and chronic graft-versus-host disease.S. in 2024. Revumenib is being investigated for its effectiveness in genetically defined acute leukemias, such as those with an NPM1 mutation, while axatilimab is being explored in earlier lines of therapy and potential indications like idiopathic pulmonary fibrosis. These therapies are designed to provide meaningful clinical results, enhancing patient outcomes in challenging cancer diagnoses.71 mn in 2021. The company’s business model includes direct sales to healthcare providers and hospitals, which serve as primary customers for these specialized treatments. The pricing structure for these therapies is determined based on their innovative nature and clinical effectiveness. Revenue transactions typically occur through negotiated contracts with healthcare institutions and payers, ensuring access to their therapies for patients in need. These products are expected to expand into new markets, particularly focusing on international healthcare systems as the company establishes its presence by 2025.
Who invested in Syndax Pharmaceuticals
17 investors across 5 rounds
See all investors in Syndax Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Syndax Pharmaceuticals
Who invested in Syndax Pharmaceuticals?
Syndax Pharmaceuticals has 17 investors on record across 5 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Syndax Pharmaceuticals raised?
Syndax Pharmaceuticals has raised 5 venture rounds. Sign up free to see how much each round raised and the total.
When did Syndax Pharmaceuticals last raise money?
Syndax Pharmaceuticals's most recent round on record is a Series C, in Aug 2015.
What does Syndax Pharmaceuticals do?
Syndax Pharmaceuticals is a pharmaceuticals company.
Where is Syndax Pharmaceuticals headquartered?
Syndax Pharmaceuticals is headquartered in New York, US.
Which VCs invest in companies like Syndax Pharmaceuticals?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Syndax Pharmaceuticals's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series C
Raising like Syndax Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.